K. Theil

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

M. Slovak, F. Appelbaum, C. Willman, 2000, Blood.

The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy

M. Scholl, S. Ezzone, S. Penza, 2000, Bone Marrow Transplantation.

HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.

M. Grever, T. Grogan, J. Licht, 1994, Blood.